Disposition of polyoxyethylated excipients in humans: implications for drug safety and formulation approaches

Clin Pharmacol Ther. 2003 Nov;74(5):509-10. doi: 10.1016/j.clpt.2003.08.004.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Area Under Curve
  • Chemistry, Pharmaceutical*
  • Excipients / adverse effects
  • Excipients / pharmacokinetics*
  • Half-Life
  • Humans
  • Polyethylene Glycols / adverse effects
  • Polyethylene Glycols / pharmacokinetics*
  • Polysorbates / adverse effects
  • Polysorbates / pharmacokinetics

Substances

  • Excipients
  • Polysorbates
  • cremophor
  • Polyethylene Glycols